AMARIN CORP PLC\UK Operating Expenses
AMARIN CORP PLC\UK (AMRN) reported Operating Expenses of $27.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-07-29
- AMARIN CORP PLC\UK operating expenses for the quarter ending 2026-06-30 was $27.00M, a 59.31% decline year-over-year.
- AMARIN CORP PLC\UK operating expenses for the quarter ending 2026-03-31 was $29.10M, a 30.52% decline year-over-year.
- AMARIN CORP PLC\UK operating expenses for the quarter ending 2025-12-31 was $29.49M, a 31.34% decline year-over-year.
- AMARIN CORP PLC\UK operating expenses for the quarter ending 2025-09-30 was $33.31M, a 19.62% decline year-over-year.
- AMARIN CORP PLC\UK operating expenses for fiscal 2025 was $171.04M, a 1.24% decline from fiscal 2024.
- AMARIN CORP PLC\UK operating expenses for fiscal 2024 was $173.18M, a 25.72% decline from fiscal 2023.
- AMARIN CORP PLC\UK operating expenses for fiscal 2023 was $233.13M, a 33.08% decline from fiscal 2022.
- AMARIN CORP PLC\UK operating expenses for fiscal 2022 was $348.35M, a 22.82% decline from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month | Operating Expenses 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $27.00M 10-Q · filed 2026-07-29 | $56.10M 10-Q · filed 2026-07-29 | $85.60M derived: sum of 3 quarters · filed 2026-07-29 | $118.91M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2026-03-31 | $29.10M 10-Q · filed 2026-04-29 | $58.60M derived: sum of 2 quarters · filed 2026-04-29 | $91.91M derived: sum of 3 quarters · filed 2026-04-29 | $158.25M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2025-12-31 | $29.49M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $62.80M derived: sum of 2 quarters · filed 2026-03-02 | $129.15M derived: sum of 3 quarters · filed 2026-07-29 | $171.04M 10-K · filed 2026-03-02 | ||||
| 2025-09-30 | $33.31M 10-Q · filed 2025-10-29 | $99.66M derived: sum of 2 quarters · filed 2026-07-29 | $141.54M 10-Q · filed 2025-10-29 | $184.50M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2025-06-30 | $66.35M 10-Q · filed 2026-07-29 | $108.23M 10-Q · filed 2026-07-29 | $151.19M derived: sum of 3 quarters · filed 2026-07-29 | $192.63M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2025-03-31 | $41.88M 10-Q · filed 2026-04-29 | $84.84M derived: sum of 2 quarters · filed 2026-04-29 | $126.28M derived: sum of 3 quarters · filed 2026-04-29 | $169.58M derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2024-12-31 | $42.95M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $84.40M derived: sum of 2 quarters · filed 2026-03-02 | $127.69M derived: sum of 3 quarters · filed 2026-03-02 | $173.18M 10-K · filed 2026-03-02 | ||||
| 2024-09-30 | $41.44M 10-Q · filed 2025-10-29 | $84.74M derived: sum of 2 quarters · filed 2025-10-29 | $130.22M 10-Q · filed 2025-10-29 | $180.19M derived: sum of 4 quarters · filed 2026-03-02 | ||||
| 2024-06-30 | $43.29M 10-Q · filed 2025-07-30 | $88.78M 10-Q · filed 2025-07-30 | $138.74M derived: sum of 3 quarters · filed 2026-03-02 | $190.01M derived: sum of 4 quarters · filed 2026-03-02 | ||||
| 2024-03-31 | $45.49M 10-Q · filed 2025-05-07 | $95.45M derived: sum of 2 quarters · filed 2026-03-02 | $146.72M derived: sum of 3 quarters · filed 2026-03-02 | $213.35M derived: sum of 4 quarters · filed 2026-03-02 | ||||
| 2023-12-31 | $49.96M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $101.23M derived: sum of 2 quarters · filed 2026-03-02 | $167.86M derived: sum of 3 quarters · filed 2026-03-02 | $233.13M 10-K · filed 2026-03-02 | ||||
| 2023-09-30 | $51.27M 10-Q · filed 2024-10-30 | $117.90M derived: sum of 2 quarters · filed 2024-10-30 | $183.17M 10-Q · filed 2024-10-30 | $256.36M derived: sum of 4 quarters · filed 2025-03-12 | ||||
| 2023-06-30 | $66.63M 10-Q · filed 2024-07-31 | $131.90M 10-Q · filed 2024-07-31 | $205.09M derived: sum of 3 quarters · filed 2025-03-12 | $273.09M derived: sum of 4 quarters · filed 2025-03-12 | ||||
| 2023-03-31 | $65.27M 10-Q · filed 2024-05-01 | $138.46M derived: sum of 2 quarters · filed 2025-03-12 | $206.46M derived: sum of 3 quarters · filed 2025-03-12 | $312.92M derived: sum of 4 quarters · filed 2025-03-12 | ||||
| 2022-12-31 | $73.19M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-12 | $141.19M derived: sum of 2 quarters · filed 2025-03-12 | $247.66M derived: sum of 3 quarters · filed 2025-03-12 | $348.35M 10-K · filed 2025-03-12 | ||||
| 2022-09-30 | $68.00M 10-Q · filed 2023-11-01 | $174.47M derived: sum of 2 quarters · filed 2023-11-01 | $275.16M 10-Q · filed 2023-11-01 | $372.89M derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2022-06-30 | $106.46M 10-Q · filed 2023-08-02 | $207.16M 10-Q · filed 2023-08-02 | $304.88M derived: sum of 3 quarters · filed 2024-02-29 | $429.78M derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2022-03-31 | $100.70M 10-Q · filed 2023-05-03 | $198.42M derived: sum of 2 quarters · filed 2024-02-29 | $323.32M derived: sum of 3 quarters · filed 2024-02-29 | $436.88M derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2021-12-31 | $97.72M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $222.62M derived: sum of 2 quarters · filed 2024-02-29 | $336.18M derived: sum of 3 quarters · filed 2024-02-29 | $451.36M 10-K · filed 2024-02-29 | ||||
| 2021-09-30 | $124.90M 10-Q · filed 2022-10-27 | $238.46M derived: sum of 2 quarters · filed 2022-10-27 | $353.63M 10-Q · filed 2022-10-27 | $478.96M derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2021-06-30 | $113.56M 10-Q · filed 2022-08-03 | $228.74M 10-Q · filed 2022-08-03 | $354.06M derived: sum of 3 quarters · filed 2023-03-01 | $484.43M derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2021-03-31 | $115.17M 10-Q · filed 2022-05-04 | $240.50M derived: sum of 2 quarters · filed 2023-03-01 | $370.87M derived: sum of 3 quarters · filed 2023-03-01 | $473.23M derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2020-12-31 | $125.33M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $255.69M derived: sum of 2 quarters · filed 2023-03-01 | $358.06M derived: sum of 3 quarters · filed 2023-03-01 | $502.27M 10-K · filed 2023-03-01 | ||||
| 2020-09-30 | $130.37M 10-Q · filed 2021-11-03 | $232.73M derived: sum of 2 quarters · filed 2021-11-03 | $376.95M 10-Q · filed 2021-11-03 | $484.07M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-06-30 | $102.36M 10-Q · filed 2021-08-05 | $246.58M 10-Q · filed 2021-08-05 | $353.70M derived: sum of 3 quarters · filed 2022-03-01 | $445.18M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-03-31 | $144.22M 10-Q · filed 2021-04-29 | $251.34M derived: sum of 2 quarters · filed 2022-03-01 | $342.82M derived: sum of 3 quarters · filed 2022-03-01 | $423.36M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2019-12-31 | $107.12M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $198.60M derived: sum of 2 quarters · filed 2022-03-01 | $279.14M derived: sum of 3 quarters · filed 2022-03-01 | $358.01M 10-K · filed 2022-03-01 | ||||
| 2019-09-30 | $91.48M 10-Q · filed 2020-11-05 | $172.02M derived: sum of 2 quarters · filed 2020-11-05 | $250.89M 10-Q · filed 2020-11-05 | $342.49M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-06-30 | $80.54M 10-Q · filed 2020-08-04 | $159.41M 10-Q · filed 2020-08-04 | $251.00M derived: sum of 3 quarters · filed 2021-02-25 | $315.04M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-03-31 | $78.88M 10-Q · filed 2020-04-30 | $170.47M derived: sum of 2 quarters · filed 2021-02-25 | $234.50M derived: sum of 3 quarters · filed 2021-02-25 | $306.60M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2018-12-31 | $91.59M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $155.63M derived: sum of 2 quarters · filed 2021-02-25 | $227.73M derived: sum of 3 quarters · filed 2021-02-25 | $282.90M 10-K · filed 2021-02-25 | ||||
| 2018-09-30 | $64.03M 10-Q · filed 2019-11-05 | $136.13M derived: sum of 2 quarters · filed 2019-11-05 | $191.30M 10-Q · filed 2019-11-05 | $238.89M derived: sum of 4 quarters · filed 2020-02-25 | ||||
| 2018-06-30 | $72.10M 10-Q · filed 2019-07-31 | $127.27M 10-Q · filed 2019-07-31 | $174.86M derived: sum of 3 quarters · filed 2020-02-25 | $218.75M derived: sum of 4 quarters · filed 2020-02-25 | ||||
| 2018-03-31 | $55.17M 10-Q · filed 2019-05-01 | $102.75M derived: sum of 2 quarters · filed 2020-02-25 | $146.64M derived: sum of 3 quarters · filed 2020-02-25 | $191.88M derived: sum of 4 quarters · filed 2020-02-25 | ||||
| 2017-12-31 | $47.59M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $91.47M derived: sum of 2 quarters · filed 2020-02-25 | $136.71M derived: sum of 3 quarters · filed 2020-02-25 | $181.71M 10-K · filed 2020-02-25 | ||||
| 2017-09-30 | $43.89M 10-Q · filed 2018-11-01 | $89.13M derived: sum of 2 quarters · filed 2018-11-01 | $134.12M 10-Q · filed 2018-11-01 | $175.52M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-06-30 | $45.24M 10-Q · filed 2018-08-01 | $90.23M 10-Q · filed 2018-08-01 | $131.63M derived: sum of 3 quarters · filed 2019-02-27 | $171.19M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-03-31 | $44.99M 10-Q · filed 2018-05-02 | $86.40M derived: sum of 2 quarters · filed 2019-02-27 | $125.95M derived: sum of 3 quarters · filed 2019-02-27 | $164.59M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2016-12-31 | $41.40M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $80.95M derived: sum of 2 quarters · filed 2019-02-27 | $119.60M derived: sum of 3 quarters · filed 2019-02-27 | $161.35M 10-K · filed 2019-02-27 | ||||
| 2016-09-30 | $39.55M 10-Q · filed 2017-11-01 | $78.19M derived: sum of 2 quarters · filed 2017-11-01 | $119.94M 10-Q · filed 2017-11-01 | $156.81M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-06-30 | $38.64M 10-Q · filed 2017-08-02 | $80.39M 10-Q · filed 2017-08-02 | $117.26M derived: sum of 3 quarters · filed 2018-02-27 | $157.08M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-03-31 | $41.75M 10-Q · filed 2017-05-03 | $78.62M derived: sum of 2 quarters · filed 2018-02-27 | $118.44M derived: sum of 3 quarters · filed 2018-02-27 | $156.50M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2015-12-31 | $36.87M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $76.69M derived: sum of 2 quarters · filed 2018-02-27 | $114.75M derived: sum of 3 quarters · filed 2018-02-27 | $152.10M 10-K · filed 2018-02-27 | ||||
| 2015-09-30 | $39.82M 10-Q · filed 2016-11-03 | $77.88M derived: sum of 2 quarters · filed 2016-11-03 | $115.24M 10-Q · filed 2016-11-03 | $146.07M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2015-06-30 | $38.06M 10-Q · filed 2016-08-04 | $75.42M 10-Q · filed 2016-08-04 | $106.25M derived: sum of 3 quarters · filed 2017-03-01 | $139.98M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2015-03-31 | $37.35M 10-Q · filed 2016-05-05 | $68.19M derived: sum of 2 quarters · filed 2017-03-01 | $101.91M derived: sum of 3 quarters · filed 2017-03-01 | $134.74M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2014-12-31 | $30.83M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $64.56M derived: sum of 2 quarters · filed 2017-03-01 | $97.38M derived: sum of 3 quarters · filed 2017-03-01 | $129.67M 10-K · filed 2017-03-01 | ||||
| 2014-09-30 | $33.73M 10-Q · filed 2015-11-04 | $66.55M derived: sum of 2 quarters · filed 2015-11-04 | $98.84M 10-Q · filed 2015-11-04 | $137.74M derived: sum of 4 quarters · filed 2016-02-25 | ||||
| 2014-06-30 | $32.82M 10-Q · filed 2015-08-06 | $65.11M 10-Q · filed 2015-08-06 | $104.01M derived: sum of 3 quarters · filed 2016-02-25 | $149.10M derived: sum of 4 quarters · filed 2016-02-25 | ||||
| 2014-03-31 | $32.29M 10-Q · filed 2015-05-08 | $71.19M derived: sum of 2 quarters · filed 2016-02-25 | $116.28M derived: sum of 3 quarters · filed 2016-02-25 | $167.73M derived: sum of 4 quarters · filed 2016-02-25 | ||||
| 2013-12-31 | $38.90M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $83.99M derived: sum of 2 quarters · filed 2016-02-25 | $135.44M derived: sum of 3 quarters · filed 2016-02-25 | $196.54M 10-K · filed 2016-02-25 | $208.46M 10-K · filed 2014-02-27 | |||
| 2013-09-30 | $45.09M 10-Q · filed 2014-11-06 | $48.78M 10-Q · filed 2013-11-07 | $96.55M derived: sum of 2 quarters · filed 2014-11-06 | $157.65M 10-Q · filed 2014-11-06 | $165.46M 10-Q · filed 2013-11-07 | $193.61M derived: sum of 4 quarters · filed 2015-03-03 | ||
| 2013-06-30 | $51.45M 10-Q · filed 2014-08-07 | $54.29M 10-Q · filed 2013-08-08 | $112.56M 10-Q · filed 2014-08-07 | $116.69M 10-Q · filed 2013-08-08 | $148.51M derived: sum of 3 quarters · filed 2015-03-03 | $182.82M derived: sum of 4 quarters · filed 2015-03-03 | ||
| 2013-03-31 | $61.10M 10-Q · filed 2014-05-09 | $62.39M 10-Q · filed 2013-05-09 | $97.06M derived: sum of 2 quarters · filed 2015-03-03 | $131.37M derived: sum of 3 quarters · filed 2015-03-03 | $159.07M derived: sum of 4 quarters · filed 2015-03-03 | |||
| 2012-12-31 | $35.96M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-03 | $70.27M derived: sum of 2 quarters · filed 2015-03-03 | $97.97M derived: sum of 3 quarters · filed 2015-03-03 | $116.75M 10-K · filed 2015-03-03 | ||||
| 2012-09-30 | $34.31M 10-Q · filed 2013-11-07 | $62.01M derived: sum of 2 quarters · filed 2013-11-07 | $80.79M 10-Q · filed 2013-11-07 | $93.12M derived: sum of 4 quarters · filed 2014-02-27 | ||||
| 2012-06-30 | $27.70M 10-Q · filed 2013-08-08 | $46.48M 10-Q · filed 2013-08-08 | $58.81M derived: sum of 3 quarters · filed 2014-02-27 | $68.25M derived: sum of 4 quarters · filed 2014-02-27 | ||||
| 2012-03-31 | $18.78M 10-Q · filed 2013-05-09 | $31.11M derived: sum of 2 quarters · filed 2014-02-27 | $40.55M derived: sum of 3 quarters · filed 2014-02-27 | $55.77M derived: sum of 4 quarters · filed 2014-02-27 | ||||
| 2011-12-31 | $12.32M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | $21.77M derived: sum of 2 quarters · filed 2014-02-27 | $36.98M derived: sum of 3 quarters · filed 2014-02-27 | $44.16M 10-K · filed 2014-02-27 | ||||
| 2011-09-30 | $9.45M 10-Q · filed 2012-11-08 | $24.66M derived: sum of 2 quarters · filed 2012-11-08 | $31.84M 10-Q · filed 2012-11-08 | $49.17M derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-06-30 | $15.21M 10-Q · filed 2012-08-08 | $22.39M 10-Q · filed 2012-08-08 | $39.72M derived: sum of 3 quarters · filed 2013-02-28 | $49.50M derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-03-31 | $7.17M 10-Q · filed 2012-05-08 | $24.51M derived: sum of 2 quarters · filed 2013-02-28 | $34.28M derived: sum of 3 quarters · filed 2013-02-28 | $44.87M derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2010-12-31 | $17.33M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $27.11M derived: sum of 2 quarters · filed 2013-02-28 | $37.70M derived: sum of 3 quarters · filed 2013-02-28 | $45.10M 10-K · filed 2013-02-28 | ||||
| 2010-09-30 | $9.78M 10-Q · filed 2011-11-08 | $20.36M derived: sum of 2 quarters · filed 2011-11-08 | $27.77M 10-Q · filed 2011-11-08 | |||||
| 2010-06-30 | $10.59M 10-Q · filed 2011-08-09 | $18.00M 10-Q · filed 2011-08-09 | ||||||
| 2009-12-31 | $34.04M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |